The COVID-19 crisis has led to major leaps forward for telehealth, decision support and more, says Hal Wolf – but big work remains on interoperability, patient ID, social determinants and other building blocks of population health. Powered by WPeMatico
Clinical decision support and hospital resource-management are particularly important as patient numbers begin to increase again, two new JAMA studies show. Powered by WPeMatico
Northwest Medical Specialties’ palliative care consults nearly doubled. Hospice referrals increased twelvefold. The integration of palliative care with advanced cancer helped the practice reach quality benchmarks. Powered by WPeMatico
The artificial kidneys can be wearable, implanted, bioengineered, developed as a xenotransplant or chimera organ, or created using a different approach. Powered by WPeMatico
Penn Medicine Chief Information Officer Mike Restuccia says strong leadership is needed to capitalize on technology’s potential – but people are the real enablers. Powered by WPeMatico
The fines are the latest effort on OCR’s part to enforce HIPAA regulations around protected health information. Powered by WPeMatico
By centralizing access to specialty care, consults and outpatient appointments, Temple University Hospital has seen an increase in appointment adherence and overall patient experience. Powered by WPeMatico
A report from the U.S. Centers for Disease Control and Prevention found that about 1.6 million telehealth encounters occurred via four major vendors from January through March. Powered by WPeMatico
Washington, DC – As part of the Trump Administration’s ongoing national effort to prevent COVID-19 outbreaks in high risk communities, the U.S. Department of Health and Human Services (HHS) today detailed that 389,040 state-of-the-art Abbott BinaxNOW COVID-19 rapid tests have been distributed at no cost to 83 Historically Black Colleges and Universities (HCBU’s) in 24 ...
Today, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) jointly announced a $12.7 million contract with InBios International Inc., of Seattle, to expand domestic production capacity for two rapid point-of-care tests for SARS-CoV-2, the virus that causes COVID-19. The first, called the SCoV-2 Ag Detect Kit, detects ...
